Fundamentals data is not available for this company.
No recent information was found.
| Patents Ending, Eli Lilly Chases New Drugs | 01-Oct-2010 | New York Times |
| Lilly aborts inhaled insulin plans | 08-Mar-2008 | LA Times |
| Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
| Currency | US Dollars |
| Share Price | $ 47.03 |
| Change Today | $ 0.05 |
| % Change | 0.11 % |
| 52 Week High | $55.00 |
| 52 Week Low | $27.03 |
| Volume | 1,429,845 |
| Shares Issued | 156.88m |
| Market Cap | $7,378m |
| Beta | 0.00 |
| RiskGrade | 248 |
| Time | Volume / Share Price |
| 16:00 | 180,932 @ $47.03 |
| 15:59 | 156 @ $47.02 |
| 15:59 | 251 @ $47.01 |
| 15:59 | 300 @ $47.01 |
| 15:59 | 193 @ $47.03 |
You are here: research